Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
G-6-PD class IV variant anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
G-6-PD class I variant anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
G-6-PD class III variant anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Anemia due to mechanical damage |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
G-6-PD class II variant anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Polyagglutinable erythrocyte syndrome |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Anemia due to abnormality extrinsic to the red cell |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Anemia due to pentose phosphate pathway defect |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Drug-induced enzyme deficiency anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Traumatic cardiac hemolytic anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Anemia due to enzyme deficiency |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Intracorpuscular haemolytic anaemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Hemolytic anemia |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Hemolytic anemia due to hexokinase deficiency |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Chronic hemolytic anemia (disorder) |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Hemolytic anemia due to red cell enolase deficiency (disorder) |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Hemolytic anemia due to glyceraldehyde-3-phosphate dehydrogenase deficiency |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Anemia due to membrane defect |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
1 |
Upshaw-Schulman syndrome (disorder) |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
6 |
Intravascular hemolysis following ectopic pregnancy |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Intravascular hemolysis following molar pregnancy |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
A rare genetic hemolytic uremic syndrome (HUS) characterized by infantile onset of relapsing episodes of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. The episodes are often preceded by viral infections. Affected individuals typically present persistent hypertension, hematuria, and proteinuria (sometimes in the nephrotic range) and develop chronic kidney disease with age. |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
4 |
A rare type of hemolytic uremic syndrome (HUS) characterized by the triad of hemolytic anemia due to generalized thrombotic microangiopathy, thrombocytopenia, and acute kidney injury, and most commonly occurring after acute gastroenteritis due to Shiga toxin-producing enterohemorrhagic Escherichia coli or Shigella dysenteriae. Other infectious causes of HUS include Streptococcus pneumoniae, HIV, Mycoplasma pneumoniae, Histoplasmosis, and Coxsackie virus. |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
5 |
A rare disorder characterized by hemolytic anemia, associated with metabolic acidosis and 5-oxoprolinuria in moderate forms and with progressive neurological symptoms and recurrent bacterial infections in the most severe forms. Several mutations have been identified in the gene encoding glutathione synthetase, localized to chromosome 20q11.2. Transmission is autosomal recessive. |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
4 |
Glutathione synthase deficiency without 5-oxoprolinuria |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
4 |
Glutathione synthase deficiency with 5-oxoprolinuria |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
4 |
Atypical haemolytic uraemic syndrome with complement gene abnormality |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
7 |
Atypical haemolytic uraemic syndrome with anti-factor H antibodies |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
7 |
Moderate amount of hemolyzed blood detected in urine by dipstick (finding) |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Large amount of haemolysed blood detected in urine by dipstick |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Small amount of hemolyzed blood detected in urine by dipstick (finding) |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |
Trace of hemolyzed blood detected in urine (finding) |
Interprets |
True |
Hemolysis (observable entity) |
Inferred relationship |
Some |
2 |